Core Laboratories (CLB) Accounts Payables (2022 - 2026)

Core Laboratories has reported Accounts Payables for 5 years, with the latest figure at $40.0 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 3.86% year-over-year to $40.0 million; the trailing twelve-month figure through Mar 2026 stood at $40.0 million (up 3.86% YoY), and the FY2025 full-year result was $37.3 million, up 7.89% from the prior year.
• Accounts Payables for Q1 2026 stood at $40.0 million, up from $37.3 million in the prior quarter.
• The five-year high for Accounts Payables was $45.8 million in Q4 2022, with the low at $32.5 million in Q1 2024.
• Historically, Accounts Payables has averaged $37.3 million across 5 years, with a median of $36.9 million in 2025.
• Annual changes were most pronounced in 2023 — Accounts Payables retreated 26.92% — and 2025, when it grew 18.5%.
• Core Laboratories' Accounts Payables stood at $45.8 million in 2022, then dropped by 26.92% to $33.5 million in 2023, then gained by 3.11% to $34.5 million in 2024, then climbed by 7.89% to $37.3 million in 2025, then rose by 7.26% to $40.0 million in 2026.
• The last three Accounts Payables figures came in at $40.0 million (Q1 2026), $37.3 million (Q4 2025), and $36.9 million (Q3 2025), per Business Quant data.